Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45

Overview of attention for article published in Annals of Neurology, March 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 8 X users
patent: 3 patents

facebook: 8 Facebook pages

Readers on

mendeley: 101 Mendeley
citeulike: 2 CiteULike

So far, Altmetric has seen 3 patents that reference this research output.

ANTISENSE OLIGOMER COMPOUNDS

Application US-20230407301-A1

United States of America

TRANSGENIC EXPRESSION CASSETTE FOR TREATING MUSCULAR DYSTROPHY

Application WO-2023124741-A1

World Intellectual Property Organisation (WIPO)

CRISPR/CAS9 CORRECTION OF MUTATIONS IN DYSTROPHIN EXONS 43, 45 AND 52

Application WO-2021168216-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity.